Singh R P
Department of Bioregulation and Microbiology, Leprosy Research Center (National Institute of Infectious Diseases), Tokyo, Japan.
Nihon Hansenbyo Gakkai Zasshi. 1998 Jul;67(2):263-8. doi: 10.5025/hansen.67.263.
Leprosy is a dynamic disease model in which distinct Mycobacterium leprae-responsive T cell subsets play an important role in host defense and control clinical and immunological spectrum. Th1 cells are associated with tuberculoid leprosy patients that have strong M. leprae-specific CMI-DTH responses. Th2 cells are expressed in lepromatous leprosy patients that are characterized by strong humoral immune responses and lack of T cell responses. Recently cytokines are thought to play immunoregulatory role in both the protection and immunopathogenesis of the host. Recombinant cytokines for immunotherapy have been used for controlling mycobacterial infections including leprosy. The diversity of T-cell subsets contributing to Th1 and Th2 cell derived cytokines, other major cytokines of the immune system, their sources, modes of action and possible therapeutic potentials are discussed.
麻风病是一种动态疾病模型,其中不同的麻风分枝杆菌反应性T细胞亚群在宿主防御以及临床和免疫谱控制中发挥重要作用。Th1细胞与具有强烈麻风分枝杆菌特异性细胞介导免疫迟发型超敏反应(CMI-DTH)的结核样型麻风病患者相关。Th2细胞在瘤型麻风病患者中表达,其特征是具有强烈的体液免疫反应且缺乏T细胞反应。最近,细胞因子被认为在宿主的保护和免疫发病机制中都发挥免疫调节作用。用于免疫治疗的重组细胞因子已被用于控制包括麻风病在内的分枝杆菌感染。本文讨论了促成Th1和Th2细胞衍生细胞因子的T细胞亚群的多样性、免疫系统的其他主要细胞因子、它们的来源、作用方式以及可能的治疗潜力。